Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus

Journal of Virology

Volumn 76, Issue 3, 2002, Pages 1062-1070

  Djeraba, Aouatef ^a   Musset, Eugène ^a   Lowenthal, John W ^a   Boyle, David B ^a   Chaussé, Anne Marie ^a   Péloille, Michele ^a   Quéré, Pascale ^a  

^a CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MACROPHAGE ACTIVATOR CHICKEN MYELOMONOCYTIC GROWTH FACTOR; MAREK DISEASE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FLUORESCENCE; FOWLPOX VIRUS; GENE EXPRESSION; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 0036147697     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.3.1062-1070.2002     Document Type: Article

References (44)

1. Marek's disease resistance of B (MHC) heterozygotes in a cross of purebred Leghorn lines
2. Quantification of Marek's disease virus in chicken lymphocytes using the polymerase chain reaction with fluorescence detection
3. Marek's disease - A model for herpesvirus oncology
4. Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice
5. In vivo expression of cytokine mRNA in rats infected with Schistosoma mansoni
6. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk
7. Cloning and expression of the chicken interferon-gamma gene
8. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition
9. The role of the reticuloendothelial system in the immunopathology of Marek's disease
10. The role of the macrophages in Marek's disease: In vitro and in vivo studies
11. Blood nitrates and infantile methemoglobinemia
12. Nitrite and nitrate levels in patients with cirrhosis of the liver: Influence of kidney function and fasting state
13. The monoclonal antibody CVI-ChNL-68.1 recognizes cells of the monocyte-macrophage lineage in chickens
14. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model
15. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice
16. Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo
17. Inhibitory effects of macrophages against Marek's disease virus plaque formation in chicken kidney cell cultures
18. Effects of levamisole on pathogenesis of Marek's disease
19. Macrophage restriction of Marek's disease virus replication and lymphoma cell proliferation
20. Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus
21. Purification and characterization of cMGF, a novel chicken myelomonocytic growth factor
22. Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor
23. Nonspecific defence mechanism: The role of nitric oxide
24. Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5′-flanking region
25. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2
26. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1(+) cells in mice
27. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins
28. Effects of macrophage-colony-stimulating factor on cyclophosphamide-injected mouse NK1.1+ cell activity
29. Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo
30. Transformation of T-lymphocyte subsets by Marek's disease herpesvirus
31. Natural killer cell activity in chickens exposed to Marek's disease virus: Inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens
32. Presence of adherent cytotoxic cells and non-adherent natural killer cells in progressive and regressive Marek's disease tumors
33. Characterization of Marek's disease virus-infected lymphocytes: Discrimination between cytolytically and latently infected cells
34. Novel chicken CXC and CC chemokines
35. Elevated levels of NO in both unchallenged and LPS-challenged C. parvum-primed mice are attributable to the activity of a cytokine-inducible isoform of iNOS
36. Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide
37. Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: Correlation with a Th1-type cytokine response
38. The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide
39. Increased virulence of Marek's disease virus field isolates
40. Turkey herpesvirus infection in chickens: Induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease
41. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures
42. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus
43. In vivo effects of chicken myelomonocytic growth factor: Delivery via a viral vector
44. Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo